Cargando…
Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin
The purpose of this study was to develop a novel synthetic high-density lipoprotein (sHDL) nanoparticle delivery system for 10-hydroxycamptothecin (HCPT) for treatment of colon carcinoma. HDL is recognized by scavenger receptor B-I (SR-BI) over-expressed in colon carcinomas 5- to 35-fold relative to...
Autores principales: | Yuan, Yue, Wen, Jian, Tang, Jie, Kan, Qiming, Ackermann, Rose, Olsen, Karl, Schwendeman, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125756/ https://www.ncbi.nlm.nih.gov/pubmed/27920529 http://dx.doi.org/10.2147/IJN.S112835 |
Ejemplares similares
-
Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma
por: Kuai, Rui, et al.
Publicado: (2017) -
Advances in Antitumor Nano-Drug Delivery Systems of 10-Hydroxycamptothecin
por: Chen, Yukun, et al.
Publicado: (2022) -
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression
por: Guo, Yanhong, et al.
Publicado: (2017) -
Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice
por: He, Hongliang, et al.
Publicado: (2020) -
The Role of Glucuronidation in 7‐Ethyl‐10‐hydroxycamptothecin Resistance in vitro
por: Takahashi, Toshiaki, et al.
Publicado: (1997)